An interventional study of Sensorimotor-Based Balance Training and Digitally Augmented Core Stabilization in Postmenopausal Osteoporosis, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to female participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
This randomized controlled trial aims to compare the effects of sensorimotor-based balance training and digitally augmented core stabilization on postural control and fall risk in postmenopausal women with osteoporosis. Osteoporosis is a common condition in postmenopausal women that can impair balance, reduce functional mobility, and increase the risk of falls and fractures. Eligible participants will be randomly assigned to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, while Group B will receive a digitally augmented core stabilization exercise program supported through the HEP2Go platform and monitored via WhatsApp. Both groups will receive supervised physiotherapy sessions three times per week for 8 weeks. Outcome measures including postural control, fall risk, spinal alignment, core muscle endurance, proprioception, muscle strength, adherence, and usability will be assessed before and after the intervention. The findings of this study may provide evidence regarding effective physiotherapy strategies for improving balance and reducing fall risk in postmenopausal women with osteoporosis.
Osteoporosis is a progressive skeletal disorder characterized by reduced bone mineral density and deterioration of bone microarchitecture, resulting in increased bone fragility and susceptibility to fractures. Postmenopausal women are particularly affected because estrogen deficiency accelerates bone loss, leading to impaired postural stability, reduced muscle strength, proprioceptive deficits, and an increased risk of falls. Falls are a major cause of morbidity, disability, and reduced quality of life among women with osteoporosis.
Exercise-based physiotherapy is an important non-pharmacological intervention for improving balance, postural control, muscle strength, and functional mobility in individuals with osteoporosis. Sensorimotor-based balance training aims to improve proprioception, neuromuscular coordination, and postural stability through progressively challenging balance and functional activities. Core stabilization exercises focus on strengthening deep trunk muscles to improve spinal stability, posture, and movement control.
Digital rehabilitation technologies have increasingly been incorporated into physiotherapy practice to improve exercise adherence, accessibility, and patient engagement. In this study, digital augmentation will be delivered through the HEP2Go platform by providing individualized home exercise programs with exercise illustrations and written instructions. Participants in the digitally augmented group will also receive regular follow-up and adherence monitoring through WhatsApp communication with the assistance of caregivers.
This study will be conducted as a randomized controlled trial involving postmenopausal women diagnosed with osteoporosis. Eligible participants who satisfy the inclusion criteria and provide written informed consent will undergo baseline assessment and then be randomly allocated to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, whereas Group B will receive a digitally augmented core stabilization exercise program. Both interventions will be administered three times per week for 8 weeks.
Primary outcomes include postural control and fall risk. Secondary outcomes include thoracic kyphosis angle, core muscle endurance, lumbar joint position sense, trunk extensor strength, exercise adherence, and system usability. Outcome measures will be recorded before and after completion of the intervention using standardized assessment tools. Data will be analyzed using SPSS version 26 to compare within-group and between-group changes.
337 studies on the registry are indexed under Osteoporosis, Postmenopausal; 29 are open to participants now.
This study's planned enrollment of 40 is below the median of 110 across 265 interventional studies indexed under Osteoporosis, Postmenopausal.
Browse Osteoporosis, Postmenopausal studies →Riphah International University is the lead sponsor of 2,176 studies on the registry; 637 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women with severe mobility impairments.
Participants assigned to this arm will receive a structured sensorimotor-based balance training program aimed at improving postural control, proprioception, balance, and reducing fall risk in postmenopausal women with osteoporosis. The intervention consists of warm-up exercises, static and dynamic balance training, sensorimotor and proprioceptive exercises, gait and functional training, lower-limb strengthening exercises, and cool-down activities. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks, with progressive exercise intensity according to participant tolerance.
Behavioral: Sensorimotor-Based Balance Training
Participants assigned to this arm will receive a structured core stabilization exercise program enhanced through digital augmentation using the HEP2Go platform. Individualized home exercise programs containing exercise illustrations and written instructions will be provided through HEP2Go. The intervention includes warm-up, deep core muscle activation, core stabilization exercises, functional core training, postural training, and cool-down exercises. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks. Exercise adherence and progress will be monitored through regular WhatsApp communication with participants and their caregivers.
Behavioral: Digitally Augmented Core Stabilization
A supervised sensorimotor-based balance training program comprising progressive static and dynamic balance exercises, proprioceptive training, gait training, lower-limb strengthening, functional balance activities, and cool-down exercises. Sessions will be conducted three times per week for 8-12 weeks to improve postural control, balance, and functional mobility in postmenopausal women with osteoporosis.
A supervised core stabilization exercise program focusing on activation and strengthening of deep trunk muscles, postural alignment, and functional stability. Digital augmentation will be provided through the HEP2Go platform by delivering individualized home exercise programs with exercise illustrations and written instructions. Participants will also receive regular WhatsApp reminders, educational support, and adherence monitoring throughout the 8-12-week intervention period.
Postural Control (Mini-BESTest)
Postural control will be assessed using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item clinical measure of postural control. Total scores range from 0 to 28 points, with higher scores indicating better postural control.
Time frame: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.
Fall Risk
Fall risk will be assessed using the Timed Up and Go (TUG) Test. Time is recorded in seconds, with shorter completion times indicating better functional mobility and lower fall risk.
Time frame: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.
Thoracic Kyphosis Angle
Thoracic kyphosis angle will be measured using a Flexicurve ruler.
Time frame: Baseline and immediately after completion of the 8-week intervention.
Core Muscle Endurance
core muscle endurance will be assessed using the Modified McGill Trunk Endurance Test.
Time frame: Baseline and immediately after completion of the 8-week intervention
Proprioception
Lumbar proprioception will be assessed using the lumbar joint position sense repositioning error test.
Time frame: Baseline and immediately after completion of the 8-week intervention.
Trunk Extensor Muscle Strength
Trunk extensor muscle strength will be measured using a handheld dynamometer.
Time frame: Baseline and immediately after completion of the 8-week intervention.
Exercise Adherence
Exercise adherence will be evaluated using attendance records and home exercise adherence logs throughout the intervention period.
Time frame: Throughout the 8-week intervention period.
System Usability
System usability of the digitally augmented intervention will be assessed using the System Usability Scale (SUS). The SUS consists of 10 items and provides a total score ranging from 0 to 100 points, with higher scores indicating better perceived usability of the digitally augmented intervention.
Time frame: At the end of the 8-week intervention.
Plan to share: No — Individual participant data (IPD) will not be shared publicly because the dataset contains confidential participant information collected for an academic research project. Data will be stored securely and used only for the purposes of this study. Any future sharing of de-identified data will require approval from the Institutional Review Board/Ethics Committee and the principal investigator, in accordance with institutional policies and participant consent.
Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.
Of 45 non-industry interventional studies with no phase under Osteoporosis, Postmenopausal, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 9 months is below that.
Counting every sponsor, half of 48 studies reached it within 17 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Osteoporosis, Postmenopausal →
Riphah International University →